| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Director | Chief Technology Officer
2 companies
Miriam Kidron is Chief Scientific Officer at ORMP and has filed Form 4s across 2 companies. Miriam Kidron's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $6.5M at current prices.
The biggest single holding is ORMP (~$6.4M) as Chief Scientific Officer. The ORMP filings lean toward selling, a net 292,450 shares.
Miriam Kidron has 27 Form 4 filings on record from February 2015 to September 2026, across 2 companies: Chief Scientific Officer at Oramed Pharmaceuticals (ORMP), 2015–2026; Director at Lifeward (LFWD), 2026.
The 44 reported transactions were 20 stock awards, 8 option or other derivative awards, 7 dispositions back to the company and 6 open-market sales, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 4 sales worth about $1.7M.
The largest open-market sale was 89,636 shares of ORMP at an average $8.50 on August 2, 2017, about $762K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2023 | ORMP Oramed Pharmaceuticals Inc. | Chief Scientific Officer | Sell | 100,000 | $2.01 | $201,000.00 | -33.1% | +88.0% | +32.5% | |
| Aug 2, 2017 | ORMP Oramed Pharmaceuticals Inc. | Chief Scientific Officer | Sell | 89,636 | $8.50 | $761,906.00 | -54.4% | - | - | |
| Apr 19, 2017 | ORMP Oramed Pharmaceuticals Inc. | Chief Scientific Officer | Sell | 52,814 | $6.33 | $334,312.62 | -37.1% | - | - | |
| Dec 30, 2015 | ORMP Oramed Pharmaceuticals Inc. | Chief Technology Officer | Sell | 50,000 | $8.90 | $444,799.70 | -26.0% | - | - |